MAPK8 and Miyoshi myopathy: To verify the therapeutic mode of action of DTP3, following administration by the proposed clinical intravenous dosing schedule, we evaluated the induction of JNK signalling and apoptosis in tumour cells from subcutaneous MM xenografts.